ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CRVS Corvus Pharmaceuticals Inc

2.04
-0.08 (-3.77%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Corvus Pharmaceuticals Inc CRVS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.08 -3.77% 2.04 14:00:04
Open Price Low Price High Price Close Price Previous Close
2.10 1.98 2.20 2.04 2.12
more quote information »

Recent News

Date Time Source Heading
15/6/202406:15EDGAR2Form 8-K - Current report
31/5/202406:02GLOBECorvus Pharmaceuticals to Present at the Jefferies Global..
08/5/202407:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/5/202407:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202407:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202406:11EDGAR2Form 8-K - Current report
07/5/202406:01EDGAR2Form 8-K - Current report
07/5/202406:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
03/5/202406:02GLOBECorvus Pharmaceuticals to Provide Business Update and First..
02/5/202422:30GLOBECorvus Pharmaceuticals Announces Pricing of $30.6 Million..
10/4/202406:01GLOBECorvus Pharmaceuticals Announces Initiation of..
20/3/202407:02GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
19/3/202422:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
14/3/202407:02GLOBECorvus Pharmaceuticals to Provide Business Update and Fourth..
02/3/202409:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202400:30GLOBECorvus Pharmaceuticals Presents Soquelitinib Preclinical..
09/2/202408:27EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/2/202408:05GLOBECorvus Pharmaceuticals Announces Orphan Drug Designation..
07/2/202408:05GLOBECorvus Pharmaceuticals Appoints Jeffrey Arcara as Chief..
24/1/202409:00EDGAR2Form 8-K - Current report
24/1/202409:00GLOBECorvus Pharmaceuticals Announces the Passing of Board Member..
10/12/202304:00GLOBECorvus Pharmaceuticals Presents New Interim Soquelitinib..
09/12/202308:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202308:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202308:03EDGAR2Form 8-K - Current report
08/11/202308:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202308:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
03/11/202300:15GLOBECorvus Pharmaceuticals to Present New Interim Soquelitinib..
02/11/202310:31GLOBECorvus Pharmaceuticals Announces Publication of Preclinical..
01/11/202307:02GLOBECorvus Pharmaceuticals to Provide Business Update and Report..
07/9/202306:05GLOBECorvus Pharmaceuticals Confirms Planned Initiation of..
09/8/202306:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202306:01EDGAR2Form 8-K - Current report
09/8/202306:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
01/8/202322:30GLOBECorvus Pharmaceuticals to Provide Business Update and Report..
07/7/202302:59GLOBECorvus Pharmaceuticals Announces Publication of Preclinical..
29/6/202321:00GLOBECorvus Pharmaceuticals Presents New Ciforadenant Preclinical..

Your Recent History

Delayed Upgrade Clock